Abstract

BackgroundVelopharyngeal structure augmentation methods are used as alternatives to pharyngeal flap operations. Recently, we investigated the sites of velopharyngeal structure augmentation in dogs and reported that the most effective injection location is the soft palate. However, there have been no reports regarding the optimal materials for implantation or injection. In this study, we aimed to investigate the injectable materials used in soft palate augmentation in dogs to ameliorate velopharyngeal insufficiency (VPI).MethodsEndoscopic soft palate augmentation (ESPA) was performed in dogs using purified sodium hyaluronate, atelocollagen, or autogenic fat tissue. ESPA is an original technique developed by our group, and this is the first report of its performance. Moreover, we assessed the amount of nasal air leakage during inspiration at rest and during expiration under the rebreathing system at 1, 2, 3, 4, 5, and 6 months after injection of these materials.ResultsThe amount of nasal air leakage during expiration under the rebreathing system was significantly decreased in all dogs injected with the ESPA materials, but neither apnea nor hypopnea was observed.ConclusionsWe investigated the optimal materials for use in ESPA, such as purified sodium hyaluronate, atelocollagen, or autogenic fat tissue. We found that all of them reduced nasal air leakage and only autogenic fat tissue showed significant histologic differences in dogs at 6 months. This technique may also be useful for the treatment of patients with VPI.

Highlights

  • When treating patients with cleft palate, velopharyngeal insufficiency (VPI) can sometimes occur after palatoplasty

  • We aimed to investigate the injectable materials used in soft palate augmentation in dogs to ameliorate velopharyngeal insufficiency (VPI)

  • We investigated the optimal materials for use in Endoscopic soft palate augmentation (ESPA), such as purified sodium hyaluronate, atelocollagen, or autogenic fat tissue

Read more

Summary

Introduction

When treating patients with cleft palate, velopharyngeal insufficiency (VPI) can sometimes occur after palatoplasty. Patients with 22q11.2 deletion syndrome have VPI due to inadequate soft palate muscle formation. Speech therapy is the first step in the treatment of VPI. After VPI is shown to be controlled with the speech aid, pharyngeal flap surgery is performed to wean the patient off the speech aid [1,2,3]. We investigated the sites of velopharyngeal structure augmentation in dogs and reported that the most effective injection location is the soft palate. We aimed to investigate the injectable materials used in soft palate augmentation in dogs to ameliorate velopharyngeal insufficiency (VPI)

Objectives
Methods
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.